TerminatedNot Applicable

Identification of Human Biomarkers Predictive of Diabetes Remission in Type 2 Diabetes Patient (BARIAKINES)

Stopped: Inclusion difficulties

France23 participantsStarted 2023-02-27

Plain-language summary

This study focuses on identifying potentially predictive human circulating adipocyte and muscle biomarkers of diabetes remission after bariatric surgery in obese type 2 diabetic (T2D) subjects.

Who can participate

Age range

18 Years – 70 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Obese patients of at least grade 2 (body mass index ≥ 35 kg/m²) * Type 2 diabetics * About to undergo bariatric surgery at the Toulouse University Hospital * Affiliated or beneficiaries of a social security plan. * Having provided a free, informed and written consent, signed Exclusion Criteria: * Type 1 diabetic subjects or Maturity-Onset Diabetes of the Youth. * Pregnant and breastfeeding women. * Vulnerable persons as defined in the Public Health Code: protected adults (guardianship, curators), unable to express their consent.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Correlation between plasma levels of 9 target molecules and diabetes remission

Timeframe: Immediately before the Surgery (day 0)

Correlation between plasma levels of 9 target molecules and diabetes remission

Timeframe: At 3 months post-surgery

Correlation between plasma levels of 9 target molecules and diabetes remission

Timeframe: At 12 months post-surgery

Trial details

NCT IDNCT05472883

SponsorUniversity Hospital, Toulouse

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08-27

View on ClinicalTrials.gov More Type 2 Diabetes trials

Who can participate

Age range

18 Years – 70 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Correlation between plasma levels of 9 target molecules and diabetes remission

Timeframe: Immediately before the Surgery (day 0)

Correlation between plasma levels of 9 target molecules and diabetes remission

Timeframe: At 3 months post-surgery

Correlation between plasma levels of 9 target molecules and diabetes remission

Timeframe: At 12 months post-surgery